Jetstream Venture Fund Invests in Surf Therapeutics and Hill Research

April 13, 2026
Jetstream Venture Fund announced new investments in Surf Therapeutics and Hill Research, expanding its healthtech and AI portfolios. The fund's backing of Hill Research marks its first dedicated AI investment, targeting automation in clinical pharmaceutical research.

The Jetstream Venture Fund has announced two new strategic investments in Surf Therapeutics and Hill Research, expanding its healthtech and AI portfolios, according to a press release.

Surf Therapeutics, a clinical-stage healthtech startup, is developing a patented, non-invasive ultrasound neuromodulation platform to treat chronic inflammatory disorders such as rheumatoid arthritis. The company is led by CEO Nishant Doctor and aims to make its therapy available for home use.

Hill Research represents Jetstream’s first dedicated AI investment. The company’s platform uses artificial intelligence to automate and accelerate clinical pharmaceutical research, aiming to reduce both time and cost in the drug development process. Jetstream participated in a competitive funding round as Hill Research reported strong growth and traction.

Jetstream Venture Fund, managed by Xcellerant Ventures and Sweater Industries LLC, is structured as an interval fund designed to provide broader access to early-stage, high-growth investments with lower minimum commitments and no carried interest.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

04/14
Kazia Therapeutics Licenses AI-Driven SETDB1 Drug Discovery Platform from QIMR Berghofer
04/14
Senhwa Biosciences Receives NT$500 Million Commitment from GEM for AI-Driven Drug Development
04/13
Function Health Acquires Getlabs to Expand At-Home Testing Access
04/13
Decoy Therapeutics Advances AI-Driven Antiviral Platform with Google Cloud Partnership
04/13
ProQR Partners with Ginkgo Bioworks and Forms AI Advisory Board

More from: Funding

04/14
Instacart Acquires Instaleap to Expand Global Enterprise Platform
04/14
OpenAI Acquires AI Personal Finance Startup Hiro
04/14
Senhwa Biosciences Receives NT$500 Million Commitment from GEM for AI-Driven Drug Development
04/13
SK hynix Invests in Semidynamics to Develop Memory-Centric AI Chips
04/13
Function Health Acquires Getlabs to Expand At-Home Testing Access

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like